Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

• Publication date

  2009-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.5664/JCSM.27549PMID 19968016PMCID PMC2725257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing.

  2010cited by this paper
• A Multi‐Drug Intoxication Fatality Involving Xyrem® (GHB)

  2009cited by this paper
• Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.

  2009cited by this paper
• Three deaths associated with use of Xyrem.

  2009cited by this paper
• Increase in sleep-related breathing disturbances after treatment with sodium oxybate in patients with narcolepsy and mild obstructive sleep apnea syndrome: two case reports.

  2009cited by this paper
• Behavioral analyses of GHB: receptor mechanisms.

  2009cited by this paper
• Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.

  2008cited by this paper
• Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.

  2007cited by this paper
• Relative Abuse Liability of γ-Hydroxybutyric Acid, Flunitrazepam, and Ethanol in Club Drug Users

  2007cited by this paper
• Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB

  2006cited by this paper
• What's in a word? Addiction versus dependence in DSM-V.

  2006cited by this paper
• The clinical development of gamma-hydroxybutyrate (GHB).

  2006cited by this paper
• Within-Patient Variability in Clinical Presentation of Gamma-Hydroxybutyrate Withdrawal: A Case Report

  2005cited by this paper
• Gamma hydroxy butyrate abuse and dependency

  2005cited by this paper
• Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds.

  2005cited by this paper
• A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.

  2004cited by this paper
• The Abrupt Cessation of Therapeutically Administered Sodium Oxybate (GHB) Does Not Cause Withdrawal Symptoms

  2003cited by this paper
• The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users.

  2003cited by this paper
• The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.

  2003cited by this paper
• A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.

  2002cited by this paper
• Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.

  2002cited by this paper
• The presence of gamma-hydroxybutyric acid (GHB) in postmortem biological fluids.

  2001cited by this paper
• Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal.

  2001cited by this paper
• GHB: a new and novel drug of abuse.

  2001cited by this paper
• Gamma-hydroxybutyrate withdrawal syndrome.

  2001cited by this paper
• Adverse events associated with ingestion of gamma-butyrolactone--Minnesota, New Mexico, and Texas, 1998-1999.

  1999cited by this paper
• Continuous sedation during spinal anaesthesia: gamma-hydroxybutyrate vs. propofol.

  1999cited by this paper
• A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose.

  1998cited by this paper
• Clinical course of gamma-hydroxybutyrate overdose.

  1998cited by this paper
• Effects of enhancing slow-wave sleep by gamma-hydroxybutyrate on obstructive sleep apnea.

  1992cited by this paper
• The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms.

  1990cited by this paper
• Narcolepsy is a rare disease in Israel.

  1987cited by this paper
• Correlation of Blood Levels of 4‐Hydroxybutyrate with State of Consciousness

  1964cited by this paper

• Prescribing controlled substances in sleep medicine clinics: an overview of legal issues and best safety practices

  2025cites this paper
• Narcolepsy: Beyond the Classic Pentad

  2025cites this paper
• Analgesic benefits of pharmacological and nonpharmacological sleep interventions for adults with fibromyalgia: a systematic review and meta-analyses.

  2025cites this paper
• Long‐Term Daytime Use of Sodium Oxybate in Laryngeal Dystonia: A Follow‐Up Online Survey Study

  2025cites this paper
• Long-term Efficacy and Safety of Sodium Oxybate in Treating Alcohol Use Disorder: A Systematic Review and Meta-Analysis

  2024cites this paper
• Hits and misses with animal models of narcolepsy and the implications for drug discovery

  2024cites this paper
• Accidental calcium, magnesium, potassium and sodium oxybates (Xywave) overdose: mistiming of a single night’s narcolepsy medication leading to respiratory failure requiring mechanical ventilation

  2024cites this paper
• Individual differences in GHB consumption in a new voluntary GHB self-administration model in outbred rats

  2024cites this paper
• Efficacy and Safety of Sodium Oxybate in Isolated Focal Laryngeal Dystonia: A Phase IIb Double‐Blind Placebo‐Controlled Cross‐Over Randomized Clinical Trial

  2024cites this paper
• Gamma-hydroxybutyrate to promote slow-wave sleep in major depressive disorder: a randomized crossover trial

  2024cites this paper
• Calcium, magnesium, potassium, and sodium oxybates oral solution for cataplexy or excessive daytime sleepiness associated with narcolepsy

  2023cites this paper
• Somnambulism.

  2023cites this paper
• Clinical Evaluation and Management of Narcolepsy in Children and Adolescents.

  2023cites this paper
• Somnambulism: Varenicline-Induced Sleep Driving

  2023cites this paper
• Letter in reply: a letter to the editor commenting on the recent publication by AY Avidan and CA Kushida.

  2023cites this paper
• Evidence of Accidental Dosing Errors with Immediate-Release Sodium Oxybate: Data from the US Food and Drug Administration Adverse Event Reporting System

  2023cites this paper
• Pharmacologic Management of Excessive Daytime Sleepiness.

  2022cites this paper
• Acute Sodium Oxybate Intoxication: A Case Report and Review of the Literature

  2022cites this paper
• Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy

  2022influential citation
• An Update on the Misuse and Abuse Potential of Pharmacological Treatments for Central Disorders of Hypersomnolence

  2022cites this paper
• Knuckle cracking at night associated with sodium oxybate treatment

  2021cites this paper
• Wake-promoting medications

  2021cites this paper
• Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic Review

  2021cites this paper
• "Sleep-related hypermotor epilepsy vs Disorders of Arousal in adults: a step-wise approach to diagnosis".

  2021cites this paper
• Sleep Disorders in Parkinson’s Disease: Management and Case Study

  2020cites this paper
• Excessive Daytime Sleepiness

  2020cites this paper
• Cluster headache: state of the art of pharmacological treatments and therapeutic perspectives

  2020cites this paper
• The sodium in sodium oxybate: is there cause for concern?

  2020cites this paper
• Depression and suicidal thoughts in untreated and treated narcolepsy

  2020cites this paper
• Multiple drugs

  2020cites this paper
• Risk factors for prescription drug diversion among people living with HIV: a systematic scoping review.

  2020cites this paper
• Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications.

  2019cites this paper
• Sleep modulating agents.

  2019cites this paper
• An evaluation of sodium oxybate as a treatment option for narcolepsy

  2019cites this paper
• Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjects

  2019cites this paper
• Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy

  2019cites this paper
• Prescription drug diversion among people living with HIV: a systematic scoping review.

  2019cites this paper
• Long-term compliance, safety, and tolerability of sodium oxybate treatment in patients with narcolepsy type 1: a postauthorization, noninterventional surveillance study

  2018cites this paper
• Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management

  2018cites this paper
• The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act

  2018influential citation
• Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial

  2018cites this paper
• NREM sleep parasomnias as disorders of sleep-state dissociation

  2018cites this paper
• A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity

  2018cites this paper
• Narcolepsy: Diagnosis and management

  2018cites this paper
• Классификация и краткое описание лекарственных препаратов — аналогов производных гамма-аминомасляной кислоты и токсических веществ, влияющих на ГАМК-ергическую связь

  2018cites this paper
• Reducing the Clinical and Socioeconomic Burden of Narcolepsy by Earlier Diagnosis and Effective Treatment.

  2017cites this paper
• Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands.

  2017cites this paper
• Sodium Oxybate-Associated Confusion in the Older Adult.

  2017cites this paper
• An open‐label study of sodium oxybate in Spasmodic dysphonia

  2017cites this paper
• Pharmacologic Management of Excessive Daytime Sleepiness.

  2017cites this paper
• Narcolepsy

  2017cites this paper
• Management of Narcolepsy

  2016cites this paper
• Treatment Options for Narcolepsy

  2016cites this paper
• Sleep in Narcolepsy and the Effects of Modafinil

  2016cites this paper
• Dopamine and Sleep

  2016cites this paper
• Sleep Disorder Comorbidities in Narcolepsy

  2016cites this paper
• UTAH MEDICAID DUR REPORT MAY 2016 SODIUM OXYBATE

  2016influential citation
• Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series

  2016cites this paper
• Sodium oxybate (Xyrem®): A new and effective treatment for narcolepsy with cataplexy

  2015cites this paper
• Drug Treatment of Sleep Disorders

  2015cites this paper
• Update on Therapy for Narcolepsy

  2015cites this paper
• GHB for cataplexy: Possible mode of action

  2015cites this paper
• Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.

  2015influential citation
• Clinical and practical considerations in the pharmacologic management of narcolepsy.

  2015cites this paper
• Sodium oxybate: a guide to its use in narcolepsy

  2014influential citation
• Therapeutic Class Overview Attention Deficit/Hyperactivity Disorder (ADHD) Agents and Stimulants

  2014influential citation
• Sleeping Beauty Gets an Eye Exam: A Case Report and Literature Review on Narcolepsy

  2014cites this paper
• Sodium oxybate: a primer for pharmacists in the treatment of narcolepsy.

  2014cites this paper
• Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention

  2014cites this paper
• AUSTRALASIAN SLEEP ASSOCIATION POSITION STATEMENT AND GUIDELINES , REGARDING THE USE OF SODIUM OXYBATE IN THE TREATMENT OF NARCOLEPSY

  2014cites this paper
• Cataplexy—clinical aspects, pathophysiology and management strategy

  2014cites this paper
• Treatment options in narcolepsy

  2013cites this paper
• Medical Disorders Presenting with Parasomnias

  2013cites this paper
• Sodium Oxybate: A Review of Its Use in Alcohol Withdrawal Syndrome and in the Maintenance of Abstinence in Alcohol Dependence

  2013influential citation
• Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands.

  2012cites this paper
• The use of sodium oxybate to treat narcolepsy

  2012cites this paper
• Sporadic Alzheimer's Disease: The Starving Brain

  2012cites this paper
• Reconsidering GHB: orphan drug or new model antidepressant?

  2012influential citation
• Catathrenia under sodium oxybate in narcolepsy with cataplexy

  2012cites this paper
• Preference for gamma-hydroxybutyrate (GHB) in current users.

  2012cites this paper
• GHB and synthetic cathinones: clinical effects and potential consequences.

  2011cites this paper
• Does gamma-hydroxybutyrate (GHB) have a role in the treatment of alcoholism?

  2011cites this paper
• [Post-marketing surveillance systems for psychoactive prescription drug abuse].

  2011cites this paper
• Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: Results from a 14‐week, randomized, double‐blind, placebo‐controlled study

  2011cites this paper
• Sodium oxybate post-marketing surveillance.

  2011cites this paper
• Psychosis in the context of sodium oxybate therapy.

  2011cites this paper
• Targeting sleep disruption using sodium oxybate in chronic cluster headache prophylaxis

  2011cites this paper
• Long-Term Follow-Up of Patients With Narcolepsy-Cataplexy Treated With Sodium Oxybate (Xyrem)

  2011cites this paper
• Sodium Oxybate: A Potential New Pharmacological Option for the Treatment of Fibromyalgia Syndrome

  2011cites this paper
• Potential impact of drug effects, availability, pharmacokinetics, and screening on estimates of drugs implicated in cases of assault.

  2011cites this paper
• Sodium oxybate-induced sleep driving and sleep-related eating disorder.

  2011cites this paper
• Les systèmes d’évaluation de l’abus et de la dépendance des médicaments psychoactifs

  2011cites this paper
• Use of sodium oxybate (Xyrem in patients with dual diagnosis of narcolepsy and sleep apnea.

  2010cites this paper
• Xyrem (sodium oxybate) postmarketing adverse event reporting system.

  2010cites this paper
• Response from the author

  2010cites this paper
• Management of Narcolepsy in Adults

  2010cites this paper
• Sodium Oxybate in the Treatment of Narcolepsy

  2010cites this paper
• Response to “Xyrem® (sodium oxybate) postmarketing adverse event reporting system”

  2010cites this paper
• Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing

  2009cites this paper
• A Multi‐Drug Intoxication Fatality Involving Xyrem® (GHB)

  2009cites this paper